MiniMed swings to breakeven net income in Q1 FY27; net sales climb 16.6% to $843 million from year-ago quarter
MMED•Full-year outlook raised
MiniMed raised its FY2027 organic revenue growth outlook to about 10.5%; CEO Que Dallara cited accelerating U.S. growth and a strong MiniMed Flex launch.
International and U.S. sales both rise
International net sales climbed 18.1% to $603 million; U.S. net sales rose 13.1% to $240 million.
Q1 FY2027 results improve on higher sales
MiniMed posted Q1 FY2027 net sales of $843 million, up 16.6% year over year; operating income improved to $5 million from an operating loss.
Net income attributable to shareholders swung to break-even from a loss; diluted EPS improved to $0.00.
Pump sales and CGM attachment rate increase
Worldwide new pumps sold increased 7.7% to about 34,000; CGM attachment rate edged up 1 percentage point to versus the prior quarter.
